Epsilon M&A Deal Report - S2A Group (now Asten Group)

Transaction Multiples for the Valuation of Private Companies

Private Group led by Salvepar > S2A Group (now Asten Group)

Announced Date : 30 April 2014

Type : Exit ,Acquisition of Minority Stake

Deal Value : Yes

Acquirer : Private Group led by Salvepar

Target S2A Group (now Asten Group)

Target Country France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> The S2A Group is a multiregional French provider of home care from the voluntary sector and medical world, operating in

the Pays de la Loire (Aliseo),
the Midi-Pyrén&eacu ...

No EMAT : 66994

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
25/06/2013	Unimedic	Cross Pharma	Sweden	0
29/09/2014	Private group led by LBO France	Payot (Laboratoires Dr NG Payot)	France	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database